about
Interventions for treating intrahepatic cholestasis in people with sickle cell diseaseInterventions for treating intrahepatic cholestasis in people with sickle cell diseaseGlycyrrhizin versus antiviral drugs for chronic hepatitis B virus infectionGlycyrrhizin for chronic hepatitis B virus infectionResveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cellsResveratrol and liver: A systematic reviewAntioxidants in liver healthAn antioxidant resveratrol significantly enhanced replication of hepatitis C virusAlleviation of Dimethylnitrosamine-Induced Liver Injury and Fibrosis by Supplementation of Anabasis articulata Extract in RatsThe Protective Effect of Resveratrol on Concanavalin-A-Induced Acute Hepatic Injury in MiceHepatoprotective activity of Lepidium sativum seeds against D-galactosamine/lipopolysaccharide induced hepatotoxicity in animal model.NF-kappaB in liver diseases: a target for drug therapy.Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats.Glycyrrhetinic acid alleviates radiation-induced lung injury in mice.Hepatoprotective properties of extensively studied medicinal plant active constituents: possible common mechanisms.Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats.Interventions for treating intrahepatic cholestasis in people with sickle cell disease.Bio-assay guided identification of hepatoprotective polyphenols from Penthorum chinense Pursh on t-BHP induced oxidative stress injured L02 cells.Hepatoprotective effect of methanolic Tanacetum parthenium extract on CCl4-induced liver damage in rats.Hepatoprotective effects of Berberis vulgaris L. extract/β cyclodextrin on carbon tetrachloride-induced acute toxicity in mice.Sesamol loaded solid lipid nanoparticles: a promising intervention for control of carbon tetrachloride induced hepatotoxicity.The constituents of licorice (Glycyrrhiza uralensis) differentially suppress nitric oxide production in interleukin-1β-treated hepatocytes.Protective effects of quercetin and quercetin-5',8-disulfonate against carbon tetrachloride-caused oxidative liver injury in mice.Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.Hepatoprotective and antioxidant activity of Melaleuca styphelioides on carbon tetrachloride-induced hepatotoxicity in mice.Hepatoprotective action of Echinophora platyloba DC leaves against acute toxicity of acetaminophen in rats.Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic rats.In vitro and in vivo antioxidant activities of inulin.Attenuation of carbon tetrachloride-induced hepatic injury with curcumin-loaded solid lipid nanoparticles.High levels of circulating HMGB1 as a biomarker of acute liver failure in patients with viral hepatitis E.Characterization of Polysaccharides with Antioxidant and Hepatoprotective Activities from the Edible Mushroom Oudemansiella radicata.Quercetin ameliorates liver injury induced with Tripterygium glycosides by reducing oxidative stress and inflammation.Hepatoprotective Effects of Nonpolar Extracts from Inflorescences of Thistles Cirsium vulgare and Cirsium ehrenbergii on Acute Liver Damage in Rat.Hepatoprotective and antioxidant effect of ellagitannins and galloyl esters isolated from Melaleuca styphelioides on carbon tetrachloride-induced hepatotoxicity in HepG2 cells.Consumption of Goats' Milk Protects Mice From Carbon Tetrachloride-Induced Acute Hepatic Injury and Improves the Associated Gut Microbiota Imbalance.The Liver Protection Effects of Maltol, a Flavoring Agent, on Carbon Tetrachloride-Induced Acute Liver Injury in Mice via Inhibiting Apoptosis and Inflammatory Response
P2860
Q24187279-C36227C1-03CD-46DA-B036-7A6B880E2163Q24200803-FE150EB3-543A-443F-ACF0-C3E915ADB5DAQ24234383-1212FECA-434A-4183-9571-848A3A6339C1Q24235137-B5FE805F-0CE1-475B-8E9F-7B2DF893B351Q24626209-1B75B08C-DDF5-4900-BB2C-EB1683A41792Q26776252-5BC16A33-E1D1-4A53-8A7D-2DE2CD718330Q26799415-BB980ECB-C78A-4004-9180-C79D67E668C3Q27490799-9386E4F3-5AF3-4087-9403-42E2367C9249Q34246819-CAA7885E-8A44-46D4-B42D-FED06D3843D5Q35690783-8FA8A222-092D-4CBF-AAC2-C9506BA2FA68Q36212244-0698D360-9E34-4F73-8D35-B88C3D03AC12Q37303995-9EC8116C-3106-4821-8CBD-080CD35BDDE8Q37409608-A7D57007-A3BD-4BFB-8833-8751C8DEA04CQ37659314-CB86C2BA-79BB-4AE0-910B-C186EBEADAAAQ38285675-310D1D5C-B754-40F6-B59F-52E735CC3BC1Q38419580-EEA979EE-02B3-46A6-B771-CCD3E7E6D633Q38651517-D68F13EA-9C0B-4F66-B831-CDA728B535A4Q38780349-CE96610E-43F6-4750-B016-0ECC973C9DC2Q41678818-1E200C0E-AAC0-4CCD-8ADB-56AB4FB664F5Q42021481-7FABC876-B26C-4EAE-AA98-4EE0FD12A9E1Q42207073-53FFCE8B-2C96-4ADC-93C3-5630BD00B32AQ43942270-756C7022-8A80-43F2-B849-B44EA7EC8EE4Q45922950-F83F4D8B-6D2F-45D0-B996-85CFEE22F043Q46147603-35E40942-0E65-4430-87F1-C0B91603599CQ46564480-FEC255F7-5BC4-45FD-99CB-B29A31A75C8CQ46980320-CE51C79B-7EFD-4AE5-A77C-FCCE1BC2FAE9Q47098684-DB45F000-9C14-4D6F-A934-155105599E24Q48114040-4641ADD1-5EB0-46A8-8184-05601DE36D90Q48345993-DA1A167F-F996-4B27-8003-A6B931CCC11CQ50234607-97FB202F-5979-490A-908F-1C7DBD39EC75Q51016244-6A7DD9A3-F725-43BA-8272-122F8F12EB51Q51638519-86CF452A-3ED1-4FB3-B05B-8B2C8AE30692Q52680613-070ACC71-C71F-4673-A555-06CFFDCCDEDCQ55059513-2D057901-812F-4EEF-91F8-9BA8A23DFD3BQ55121958-C3322995-AE87-4524-8E4C-87D3D9CE495FQ58696577-49F67E2F-7ECE-4DA7-9B9F-494B36AFF4E1
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Beneficial drugs for liver diseases.
@en
type
label
Beneficial drugs for liver diseases.
@en
prefLabel
Beneficial drugs for liver diseases.
@en
P2860
P356
P1476
Beneficial drugs for liver diseases.
@en
P2093
Pablo Muriel
Yadira Rivera-Espinoza
P2860
P304
P356
10.1002/JAT.1310
P407
P577
2008-03-01T00:00:00Z